E-Book, Englisch, 201 Seiten
Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines.
E-Book, Englisch, 201 Seiten
Reihe: World Review of Nutrition and DieteticsISSN
ISBN: 978-3-8055-9428-8
Verlag: S. Karger
Format: EPUB
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Ernährungsmedizin, Diätetik
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Essstörungen & Therapie
Weitere Infos & Material
1;Cover;1
2;Contents;6
3;List of Contributors;8
4;Preface;12
5;Opportunities and Challenges in Nutrigenetics/Nutrigenomics and Health;22
5.1;Why Nutrigenetics/Nutrigenomics?;22
5.2;Opportunities;23
5.3;Challenges;25
5.4;How to Deal with the Challenges;27
5.5;References;27
6;Genome-Wide Association Studies and Diet;29
6.1;Monogenic Disorders and Complex Disease;30
6.2;Enabling Technologies in GWAS;31
6.3;GWAS: Why Are They Important?;31
6.4;Use of Gene Chips and GWAS Datasets in Personalized Health Predictions;32
6.5;Gene-Diet Interactions: Crohn’s Disease;33
6.6;Acknowledgments;34
6.7;References;34
7;Copy Number Variation, Eicosapentaenoic Acid and Neurological Disorders;36
7.1;Ethyl-EPA;36
7.2;Huntington’s Disease;37
7.3;Myalgic Encephalomyelitis;38
7.4;Conclusions;39
7.5;References;39
8;Nutrigenetics: A Tool to Provide Personalized Nutritional Therapy to the Obese;42
8.1;Observational Studies Evidencing Gene-Nutrient Interactions on Weight Gain;43
8.2;Intervention Studies Concerning Genetic Modification Effects on Weight Loss and Maintenance;46
8.3;Nutritional Studies Concerning Gene-Dependent Effects on Obesity-Related Manifestations;49
8.4;Conclusions;51
8.5;References;51
9;Xenobiotic Metabolizing Genes, Meat-Related Exposures, and Risk of Advanced Colorectal Adenoma;55
9.1;Materials and Methods;56
9.2;Results;57
9.3;Discussion;59
9.4;Acknowledgments;62
9.5;References;64
10;Strategies to Improve Detection of Hypertension Genes;67
10.1;Subject Selection;68
10.2;Selecting an Intervention;69
10.3;Study Time Windows;69
10.4;Tissue versus Central Phenotype Measurement;70
10.5;Intervention Studies;72
10.6;Improving Genome-Wide Association Results;73
10.7;Summary;74
10.8;Acknowledgments;74
10.9;References;75
11;Diet, Nutrition and Modulation of Genomic Expression in Fetal Origins of Adult Disease;77
11.1;Epidemiology;78
11.2;Experiments of Nature;79
11.3;Cancer Risk and Early Life;80
11.4;Growth and Development;81
11.5;Size and Body Composition at Birth;83
11.6;Developmental Plasticity;84
11.7;Animal Models;84
11.8;Epigenetics and Cancer;88
11.9;Conclusion;88
11.10;References;90
12;Choline: Clinical Nutrigenetic/Nutrigenomic Approaches for Identification of Functions and Dietary Requirements;94
12.1;Challenges for Clinical Nutrigenetics/Nutrigenomics;94
12.2;Other Considerations before Undertaking Clinical Nutrigenetics/Nutrigenomics;96
12.3;Prototype Experiment in Nutrigenetics/Nutrigenomics: Studies on Choline Deficiency;96
12.4;Choline Metabolism;96
12.5;Consequences of Dietary Choline Deficiency in Humans;97
12.6;Genetic Variation in Dietary Requirements for Choline;99
12.7;Choline and Neural Development;99
12.8;Choline Deficiency Alters Gene Expression via Epigenetic Mechanisms;100
12.9;Long-Lasting Consequences of Prenatal Choline Availability;100
12.10;Implications for Human Brain Development;101
12.11;Acknowledgments;101
12.12;References;101
13;Dietary Polyphenols, Deacetylases and Chromatin Remodeling in Inflammation;105
13.1;Polyphenols: An Overview;106
13.2;Modulation of Inflammation by Polyphenols;106
13.3;Deacetylases and Inflammation;108
13.4;Modulation of Deacetylases by Dietary Polyphenols;109
13.5;Conclusions;112
13.6;Acknowledgments;113
13.7;References;113
14;Dietary Manipulation of Histone Structure and Function;116
14.1;Use of Histone Deacetylase Inhibitors in Cancer Prevention;117
14.2;Dietary Inhibitors of Histone Deacetylases;118
14.3;Future Directions and Conclusions;120
14.4;Acknowledgments;121
14.5;References;122
15;Changes in Human Adipose Tissue Gene Expression during Diet-Induced Weight Loss;124
15.1;Obesity;124
15.2;Obesity Treatment;125
15.3;Adipose Tissue;125
15.4;Expression Profiling of Human Adipose Tissue during Diet-Induced Weight Loss;126
15.5;Serum Amyloid A Expression in Human Adipose Tissue and Association with Metabolic Disease;129
15.6;CIDE Family;130
15.7;A Local Activin B Signaling System in Adipose Tissue?;131
15.8;Conclusions;132
15.9;Acknowledgments;132
15.10;References;132
16;Toxicogenomics and Studies of Genomic Effects of Dietary Components;136
16.1;Reference Materials and Methods to Improve and Monitor Laboratory Proficiency in Microarray Assays;137
16.2;Identification of Factors that Increase Biological Noise in Gene Expression Studies;138
16.3;Phenotypic Anchoring to Supply a Biological Context for Interpreting Gene Expression Data;140
16.4;Reference Sets that Aid in the Interpretation of Adverse versus Adaptive Effects;141
16.5;Conclusions;142
16.6;Disclaimer;142
16.7;References;142
17;Dietary Methyl Deficiency, microRNA Expression and Susceptibility to Liver Carcinogenesis;144
17.1;Materials and Methods;145
17.2;Results and Discussion;146
17.3;Disclaimer;150
17.4;References;150
18;Redox Dysregulation and Oxidative Stress in Schizophrenia: Nutrigenetics as a Challenge in Psychiatric Disease Prevention;152
18.1;Redox/Glutathione Dysregulation Is a Vulnerability Factor in Schizophrenia;155
18.2;Pathophysiological Mechanisms;157
18.3;Developmental Animal Models with Redox Dysregulation;159
18.4;Therapeutic and Preventive Perspectives;162
18.5;Conclusion;167
18.6;Acknowledgments;167
18.7;References;167
19;Nutrigenomics and Agriculture: A Perspective;175
19.1;Genomic Prediction in Dairy Cows;175
19.2;Dietary Guidance;176
19.3;Discussion;178
19.4;References;180
20;Opportunities and Challenges in Nutrigenetics/Nutrigenomics: Building Industry-Academia Partnerships;181
20.1;The Challenge before Us;181
20.2;Accelerated Learning Curves;181
20.3;Professional Development and Building Networks;184
20.4;Sharing Science;184
20.5;Anatomy of a Partnership Model in Molecular Nutrition;184
20.6;Final Thoughts;188
20.7;Disclosures;188
20.8;References;189
21;Tailoring Foods to Match People’s Genes in New Zealand: Opportunities for Collaboration;190
21.1;Role of Genetics in CD in New Zealand;190
21.2;Modeling Genetic Variation in Human CD Populations in vitro;192
21.3;Estimating the Role of Diet in CD;193
21.4;Animal Models of IBD;194
21.5;Double-Blind Placebo Controlled Human Clinical Trials;194
21.6;Data Management and Integration;195
21.7;Acknowledgments;195
21.8;References;195
22;Author Index;197
23;Subject Index;198